TFF Pharmaceuticals announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 25 pre-split shares. The reverse stock split will become effective at 12:01 A.M. Eastern Time, on December 19, 2023. The Company’s common stock will continue to be traded on the Nasdaq Capital Market under the symbol “TFFP” and will begin trading on a split-adjusted basis when the market opens on December 19, 2023.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TFFP:
- TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors
- TFF Pharmaceuticals appoints Thomas King to board of directors
- TFF Pharmaceuticals appoints Catherine Lee to board of directors
- TFF Pharmaceuticals appoints Michael Patane to board of directors
- TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors